Ohio State University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Ohio State University sits in the top decile of US sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count).

552 total trials 117 currently recruiting 319 completed early-phase tilt top decile by trial count

Ohio State University: 552 sponsored US clinical trials, 117 recruiting.

Ohio State University sponsors 552 registered US clinical trials on ClinicalTrials.gov, 117 of them currently recruiting, and 319 completed. 39 of these trials are in Phase 3-4 (later-stage) and 60 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Suicidal Ideation, with 8 trials.

Top-decile sponsor footprint

Ohio State University ranks in the top decile of sponsors by registered trial count (#66 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 57/100

319 of 366 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

552 total, page 6 of 12

COMPLETED NA

Evaluation of Wear Experience With Daily Contact Lenses

NCT05096156

COMPLETED NA

Assessing the Utility of MMPI-2-RF-EX in Detecting Simulated Underreporting of Current Suicide Risk in Military Veterans

NCT04896151

COMPLETED NA

Wear Experience With Daily Toric Contact Lenses Over a Long Day

NCT04844281

COMPLETED NA

OUR Stress/ Emotion Management for Black/African American Women With Hypertension

NCT04526145

COMPLETED

Using Virtual Technologies to Prevent Injuries in Adolescents With Acquired Brain Injury

NCT04768946

TERMINATED Phase 4

A Randomized Controlled Trial of Treatment of Bacterial Vaginosis

NCT04578015

COMPLETED NA

Novel Multimodal Pain Control Protocol for Minimally Invasive Gynecologic Surgery

NCT04710277

COMPLETED NA

A Randomized Clinical Trial Testing the Effectiveness of Telemental Health for Suicidal Patients

NCT04844294

COMPLETED

Arm and Ankle Blood Pressure Cuffs During C-Section

NCT04934995

COMPLETED

The Use of a Consumer-Based mHealth Dietary App and Health Coaching With Kidney Transplant Recipients

NCT05151445

COMPLETED NA

Use of Cheetah® Cardiac Monitoring System to Guide Discontinuation of Magnesium Sulfate in Women With Severe Preeclampsia

NCT04474704

COMPLETED NA

Learning and Improving Alzheimer's Patient-Caregiver Relationships Via Smart Healthcare Technology

NCT04536701

COMPLETED NA

Using Mental Imagination to Prevent Excessive Gestational Weight Gain in Overweight and Obese Pregnant Women

NCT04623008

COMPLETED NA

Lifestyle Behavior Weight Loss Intervention

NCT04649047

COMPLETED

Glycemic Control Based on Serum Fructosamine Concentration vs. hemoglobinA1c (HbA1c) in Diabetic Patients

NCT04079660

COMPLETED

MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users

NCT03978793

COMPLETED NA

Protecting Home Healthcare Workers: An Interactive Video-based App to Coach Workers Through Challenging Health and Safety-related Situations

NCT04593901

COMPLETED NA

Improving Treatment Outcomes for Suicidal Veterans With PTSD

NCT04690582

COMPLETED NA

Cognitive Behavioral Therapy for Depression: Helping Clients Learn New Skills

NCT04673513

COMPLETED NA

Improving Cardiovascular Risk Factors in Black Young Adults

NCT04412954

COMPLETED Phase 4

Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance

NCT04412096

COMPLETED NA

Brief Video Interventions for Depression

NCT04643964

COMPLETED NA

Responses to Information on Treatments for Depression

NCT04639765

COMPLETED NA

Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for PTSD - COVID Related Substudy

NCT04540939

COMPLETED NA

Southeast Asian Women's Health Project

NCT04086771

COMPLETED NA

Wear Experience With Daily Contact Lenses Over a Long Day

NCT04535310

COMPLETED

ROTEM® Obstetric Hemorrhage Pilot Study

NCT04409015

COMPLETED NA

Prevention of OUD: The HOME Project (Housing, Opportunities, Motivation and Engagement)

NCT04135703

COMPLETED Phase 4

Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor

NCT04392375

COMPLETED

Endoscopic Esophageal Topography (Endoflip 2.0) Versus High-resolution Manometry (HRM)

NCT05089929

COMPLETED NA

Evaluation of Wear Experience With a Daily Disposable Contact Lens

NCT04296877

COMPLETED NA

Microfragmented Adipose Tissue Versus Platelet-rich Plasma for Knee Osteoarthritis: a Randomized Comparative Trial

NCT04351087

COMPLETED

Standing Balance as the Fifth Vital Sign in Clinical Setting

NCT04139642

COMPLETED NA

Creating Healthier Communities Through Meaningful Partnerships: A Model From the National African American Male Wellness Initiative - OSU Partnership

NCT04787978

COMPLETED NA

PRP vs PRP Plus IGF for Patellar Tendinosis

NCT04350827

COMPLETED NA

Improving Print Knowledge for Children With Hearing Loss

NCT04027881

TERMINATED NA

Ketogenic Diet in Patients With Heart Failure

NCT04235699

COMPLETED

Pain and Acetaminophen in Women Study

NCT04573426

TERMINATED NA

A Randomized, Pilot Study Comparing Cost Effectiveness on Two Commercially Available Gastric Feeding Tubes

NCT04030871

TERMINATED

Validation of a Quality of Life Metric "Prolac-10"

NCT04106531

COMPLETED

SAGE for the Early Detection of Cognitive Impairment at Primary Care Provider Visits

NCT04063371

COMPLETED Early Phase 1

Aspirin Effects on Emotional Reactions

NCT04146532

COMPLETED NA

Implementation of Multidisciplinary Assessments for Geriatric Patients in an ED Observation Unit

NCT04068311

COMPLETED Phase 2

Sirolimus for Cowden Syndrome With Colon Polyposis

NCT04094675

COMPLETED

Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control

NCT04080128

COMPLETED

Clinical and Radiological Outcomes of Posterior Cervical Fusion with Medtronic Infinity Occipitocervical-Upper Thoracic (OCT) System

NCT04056520

COMPLETED

Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia

NCT04063397

TERMINATED Phase 4

Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.

NCT03756454

COMPLETED NA

Teaching Parents Reiki for Their Adolescents Receiving Palliative Care

NCT03896165

COMPLETED NA

Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD)

NCT03874793

← Previous Page 6 of 12 Next →

Phase Distribution

PhaseTrial count
Phase 1 35
Phase 2 25
Phase 3 5
Phase 4 34

What is open in the Ohio State University pipeline

117 recruiting of 552 indexed (21% open); 319 completed (58%).

Phase mix: 39 late (III/IV) vs 60 early (I/II) (early-phase heavy).

Top condition: Suicidal Ideation (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Ohio State University: open-pipeline peers nationwide

Peers matched on 552 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 5%10%15%20%25% Total trials Recruiting share Ohio State UniversityAmgenMerck Sharp & DohmeVirginia Commonwealth UniversityOregon Health and Science UniversityUniversity of LouisvilleMedical College of WisconsinNova Southeastern UniversityColorado State University
Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Ohio State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 552 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this Ohio State University page

552 registered trials is a research-attention snapshot, not an endorsement of Ohio State University or any single study.

  • 117 of Ohio State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Suicidal Ideation is the condition Ohio State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Suicidal Ideation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Ohio State University pipeline card: 552 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.